Jiangsu Hengr.Pharmac. Co.Ltd. Registered Shares H YC 1

Sector and Industry

Healthcare, Biopharmaceuticals

Performance (1Y)

20.38%

Market Cap

-

P/E Ratio

55.38

Dividend Yield

0.32 %

Earnings per Share

0.15 €

Peer Group

Company NameMarket CapRevenue Last Reported YearP/E RatioProfit Growth 1YLast PricePrevious Trading Day Change
Eli Lilly and Company864.54 Bil.57.78 Bil.46.82
+86.88 %
0.00
-
Johnson & Johnson425.70 Bil.83.48 Bil.18.82
+82.71 %
0.00
-
AbbVie Inc.343.94 Bil.54.21 Bil.96.78
-5.29 %
0.00
-
Roche Holding AG286.62 Bil.65.80 Bil.20.72
+58.45 %
0.00
-
AstraZeneca PLC244.91 Bil.52.09 Bil.27.55
+39.41 %
0.00
-
NOVARTIS AG 224.76 Bil.48.44 Bil.18.30
+12.45 %
0.00
-
Merck & Co. Inc.221.79 Bil.57.55 Bil.14.46
+2.25 %
0.00
-
Novo-Nordisk AS B193.52 Bil.41.49 Bil.14.11
+1.54 %
0.00
-
Amgen Inc.150.16 Bil.32.57 Bil.23.01
+80.77 %
0.00
-
Gilead Sciences Inc.129.70 Bil.26.10 Bil.18.10
+1,599.93 %
0.00
-

Facts & figures

Price data

TRADE PLATFORMBörse Stuttgart (XSTU)
LAST PRICE6.25 G0 Units
PRICE DETERMINATION TIME07/24/2026 / 09:56:45 PM
DAILY VOLUME (UNITS)0
DAILY HIGH / LOW6.36.2
PREV. DAY'S PRICE6.35 (07/23)
CHANGE DAY BEFORE
-0.10
-1.57 %
52 WEEK HIGH / LOW10.3 (10/07)5.6 (06/11)
More Price Information

Key Figures (in EUR)

2023202420252026e2027e
EARNINGS PER SHARE
0.090.130.15--
DIVIDENDS PER SHARE
0.020.020.03--
DIVIDEND YIELD IN %
--0.32 %--
DIVIDEND GROWTH IN %
21.61 %0.28 %9.54 %--
PRICE - EARNINGS RATIO
--55.38--
PRICE - BOOK RATIO
--6.89--
PRICE - SALES RATIO
--13.61--
PRICE - CASH FLOW RATIO
--37.89--
Further Key Figures

Master Data

WKN
A41984
ISIN
CNE100006XS6
SYMBOL
0BO
EXCHANGE SEGMENT
Freiverkehr
TYPE OF FINANCIAL INSTRUMENT
Equity
DENOMINATION
JIANGSU HENG.PHAR. H YC 1
INDEX MEMBERSHIP
-
TRADING SEGMENT
-
TRADING HOURS
07:30:00 AM - 10:00:00 PM
TRADING CURRENCY
Euro
NOMINAL CURRENCY
-
SETTLEMENT CURRENCY
Euro
SECTOR AND INDUSTRYHealthcare, Biopharmaceuticals
NUMBER OF SHARES
-
MARKET CAPITALISATION
-

Performance overview

1W1M3M6M1Y3Y5YYTD
PERFORMANCE
4.17 %
-0.79 %
-15.54 %
-20.38 %
-20.38 %
--
-18.30 %
HIGH6.506.757.607.9010.30--8.80
LOW6.205.855.605.605.60--5.60

Dividende

pro Aktie

Company profile

Jiangsu Hengrui Pharmaceuticals Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical products. It specializes in antineoplastic agents, surgical anesthesia drugs, features infusion, contrast agents, and cardiovascular drugs. Its products include tablets, oral solution, and suspension of antineoplastic drugs and narcotic drugs, psychotropic substances, soft capsules, freeze-dried powder injection, powder injection, high-volume injection including multi-layer co-extruded infusion bag with anti-tumor drugs, small volume injections including antineoplastic drugs, psychotropic drugs, and non-final sterilization, biological engineering products such as polyethylene glycol recombinant human granulocyte stimulating factor injection, hard capsules, granules, powder, and film and gel. The company was founded in 1970 and is headquartered in Lianyungang, China.

Shareholder Structure (Top 10)

AnteilName
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available

Analyst Rating

Ø-Target Price DistanceNot Available
Current Price
Not Available
Ø-Target Price
Not Available
Average ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0

Company Events

No company events available.